Pharmacy chains activity analysis

Pharmacy chains activity analysis

Russian pharmaceuticals retail chain segment evaluation, both on the level of the state and in particular regions. Pharmacy chains development forecast

Forecasting

Product sales and separate market development forecast, based on unique mathematical models

Business and marketing plan development

Development of detailed business-plans, required to evaluate the reasonability of project start

Search of partners for contract production in Russia

Potential partners search and evaluation, based on their technical opportunities, appropriate experience, and reputation

Monitoring of import substitution

assessment of the main trends of import substitution policies and localization processes in the pharmaceutical market in Russia, the key beneficiaries and companies at risk

News

2/16/2022 2021 Ranking of Russian Pharmaceutical Distributors

Last year’s growth rates of the Russian pharmaceutical retail market were in line with the inflation rate. While the price index was rather impressive, in the current conditions only maintaining more or less stable figures in the market seems possible, rather than development, because in fact, the market is stagnating. Besides, even those figures were mainly the result of the growing purchasing activity in the online segment, which is still developing, primarily by luring away consumers from offline pharmacies.

1/27/2022 Database Update: Audit of Veterinary Drug Retail Sales in Russia (December 2021)

In 2021, the sales of veterinary drugs in the Russian retail market amounted to 21.1 billion rubles (retail prices, VAT included), up 4% from 2020. While that seems to be a fine result, especially considering the growth rates of –0.3% in 2020, it is obvious that the inflation rate influenced the growth rates in 2021. In physical terms, the growth rates kept falling (–7.2% in monetary dosage units, or MDUs), and the total sales volume was 166.7 million MDUs.

1/26/2022 Database Update: Audit of Veterinary Drug Retail Sales on Russian Online Marketplaces (December 2021)

In 2021, the retail sales of veterinary drugs through the top online marketplaces in Russia amounted to 727.6 million rubles (retail prices, VAT included), having tripled from 2020. In physical terms, the sales increased 2.5 times from 2020, if calculated in minimum dosage units (MDU). The sales volume was 5.1 million MDUs.

1/25/2022 Survey by RNC Pharma and Medvestnik: 19% of Russian Doctors Ready to Report Vaccine-Hesitant Co-workers to Management

40% of Russian doctors do not accept “workplace snitching” in any case, according to a survey conducted by the RNC Pharma analyst company and the platform for doctors Medvestnik. Obviously, this answer had statistically significant differences between the two types of medical institutions—it was more often chosen by employees of private hospitals (48% against 34%).

12/28/2021 Database Update: Audit of Veterinary Drug Retail Sales in Russia (November 2021)

In January–November 2021, the sales of veterinary drugs in the Russian retail market amounted to 19.9 billion rubles (retail prices, VAT included), up 4.7% from January–November 2020. The offline segment is under severe pressure from the rapidly developing online business, since the online sales increased 3.2 times in monetary terms (rubles). In physical terms, the growth rate was –6.6% in monetary dosage units (MDU), with the total sales volume of 155.7 million MDUs.

12/24/2021 Pharmaceutical Drug Production in Russia (November 2021)

In January–November 2021, Russian manufacturers produced 546.4 billion rubles’ worth of pharmaceutical drugs (manufacturer’s prices, VAT included), up 20.1% from the same period in 2020. In physical terms, the production volume was 3.73 billion packages, down 16% from 2020. If calculated in minimum dosage units (MDU), the growth rate was also negative (–5.1%), with the production volume of 70.9 billion MDUs.

12/20/2021 Database Update: Audit of Veterinary Drug Retail Sales on Russian Online Marketplaces (November 2021)

In January–November 2021, the retail sales of veterinary drugs through the top online marketplaces in Russia amounted to 673.3 million rubles (retail prices, VAT included), having increased 3.2 times from January–November 2020. The sales through marketplaces accounted for 3.5% of the total veterinary retail sales against 1.2% in January–November 2020. In physical terms, the sales declined 2.7 times from 2020, if calculated in minimum dosage units (MDU). The sales volume was 4.7 million MDUs.

12/8/2021 Top 20 Online Pharmaceutical Retailers in Russia (Q1–Q3 2021)

In Q1–Q3 2021, the total volume of the online sales or reservations of pharmaceutical products (pharmaceutical drugs and parapharmaceuticals) in Russia amounted to RUB 141.6 billion (end-user prices, VAT included), 34.5% up from the same period in 2020. The total growth rate of the Russian pharmaceutical retail was just over 3%. After the disastrous results of Q1 2021, the largest growth was in Q2–Q3 2021.

12/3/2021 Ranking of Russian Pharmacy Chains (Q1–Q3 2021)

This year’s growth rates of the Russian pharmaceutical retail market are in no way comparable to those in 2020. The panic and the associated rush demand have more or less subsided. With the inflation rates at a high level, the purchasing power leaves much to be desired, even despite the impressive income growth in Q2 and Q3. In addition, conventional pharmacies are under severe pressure from various online projects, which have been adding more and more services, including express delivery, which in some situations is critical for the consumer.

11/30/2021 Ranking of Russian Pharmaceutical Distributors (Q1–Q3 2021)

The Russian State Duma of the 8th convocation intends to continue working on the draft law that introduces restrictions for the pharmaceutical retail market and wholesale companies. At the same time, it is willing to revise certain provisions, including the maximum amount of marketing bonuses. While it may seem industry-specific, both the stability of the Russian pharmaceutical retail and the pricing policy at all stages of the movement of goods directly depend on that provision.